Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Coagulation Factor VIII/von Willebrand Factor Complex in von Willebrand Disease
CTR20223046Phase 3Completed
- Sponsor
- Shandong Taibang Biological Products
- Start
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of factor viii + von Willebrand factor in von Willebrand disease (VWD), hemophilia A, acquired haemophilia (AH), sponsored by Shandong Taibang Biological Products. Started Nov 2022; status: completed.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
von Willebrand disease (VWD)hemophilia Aacquired haemophilia (AH)
Beyond the preview
Go deeper on CTR20223046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223046.